| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,232 | 45,052 | 5,660 | 57,565 | | Cost of Revenue | 23,796 | 22,175 | 1,476 | 27,763 | | | Gross Profit | 25,436 | 22,877 | 4,184 | 29,802 | | | Operating Expenses | | Research Development | 20,828 | 19,414 | 15,490 | 21,255 | | Selling General and Administrative | 11,991 | 10,519 | 3,732 | 13,418 | | Non Recurring | (125) | (154) | (33,571) | 265,201 | | Others | 1,005 | 1,005 | 60 | 1,320 | | | | Total Operating Expenses | 33,699 | 30,784 | (14,289) | 301,194 | | | | Operating Income or Loss | (8,263) | (7,907) | 18,473 | (271,392) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,425) | 1,589 | 1,693 | (7,396) | | Earnings Before Interest And Taxes | (11,688) | (6,318) | 16,903 | (275,525) | | Interest Expense |
-
|
-
|
-
| 1 | | Income Before Tax | (11,688) | (6,318) | 16,903 | (275,526) | | Income Tax Expense | (3,617) | (3,519) | (683) | (4,329) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,071) | (2,799) | 20,849 | (274,460) | | | Non-recurring Events | | Discontinued Operations | 1,347 | 5,697 | (48,235) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,724) | 2,898 | (27,386) | (274,460) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,724) | $2,898 | ($27,386) | ($274,460) |
|
0.49% Nasdaq 0.00%
Income Statement
